Drug Type Small molecule drug |
Synonyms- |
Target |
Mechanism HIV-1 pol inhibitors(Human immunodeficiency virus type 1 protease inhibitors), RT inhibitors(Reverse transcriptase inhibitors) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
Drug Highest PhasePendingNDA/BLA |
First Approval Date- |
Regulation- |
Molecular FormulaC38H54N6O11S |
InChIKeyDQSGVVGOPRWTKI-QVFAWCHISA-N |
CAS Registry229975-97-7 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
HIV Infections | NDA/BLA | US | 04 Sep 2014 |